My clinical approach
Penile lichen sclerosus is one of the most important penile conditions — not because of frequency, but because of its premalignant nature. Many patients present with "simple" adult phimosis that proves to be BXO. Correct management combines: histological confirmation, first-line medical therapy, surgery when required, and — most importantly — long-term follow-up.
In my practice I follow the EAU Penile Cancer 2024 guidelines, the BAD (British Association of Dermatologists) 2018 and the German S3 Leitlinie Kirtschig 2015:
- Biopsy ALWAYS — clinical diagnosis alone is insufficient.
- Topical clobetasol 0.05% as first line — 8–12 weeks.
- Full circumcision for phimosis or refractory disease — with histology of the whole specimen.
- Buccal mucosa graft urethroplasty for urethral stricture — not endoscopic incision (high recurrence).
- Regular surveillance: 6-monthly × 2 years, then annual × 5 years minimum.
- Biopsy of any new white plaque, ulceration or hyperkeratotic area.
- Systematic patient education: the patient must know they are monitoring their glans for life.
Correct management converts a potentially carcinogenic condition into a controlled chronic disease with excellent prognosis.
What is penile lichen sclerosus?
Penile lichen sclerosus (LS) is a chronic inflammatory skin disease of probable autoimmune aetiology, affecting the foreskin, glans and — in advanced stages — the external urethral meatus or even the spongy urethra.
The disease was previously termed Balanitis Xerotica Obliterans (BXO). Modern dermatological and urological terminology prefers Penile Lichen Sclerosus, paralleling the vulvar/perianal disease in women.
Disease characteristics:
- White sclerotic plaques with a "porcelain" appearance.
- Fibrosis and loss of skin elasticity.
- Stenosis of the foreskin ring → acquired phimosis.
- Stenosis of the external urethral meatus → dysuria.
- Premalignant character — 3–10% risk of SCC.
Causes and pathogenesis
The exact aetiology remains unknown, but the disease is considered multifactorial:
Autoimmune mechanism
Association with autoantibodies against ECM-1, with concomitant autoimmune conditions (type 1 diabetes, thyroid disease, vitiligo) in 20–30% of patients.
Köbner phenomenon — chronic irritation
Chronic exposure of the glans to urine under a tight foreskin is considered a predisposing factor. The uncircumcised state is the most frequent anatomical association.
Infectious factors
Association with Borrelia burgdorferi has been suggested in some series, but is controversial. HPV is not considered a primary cause.
Genetic predisposition
Association with certain HLA alleles (HLA-DQ7, DQ8, DQ9). Possible familial link in around 10% of cases.
Symptoms and clinical staging
Early symptoms
- White spots on glans/foreskin
- Itching
- Dyschromia (initially erythematous, then white)
- Dryness and mild scaling
Advanced symptoms
- Sclerotic "porcelain" plaques
- Phimosis (inability to retract)
- Fissures, bleeding
- Pain on erection/intercourse
- Urethral meatal stenosis
- Dysuria, weak stream
- Ulceration or hyperkeratosis (suspicious for SCC)
Clinical staging (Edmonds 2012)
- Stage I — Erythematous plaque only, no sclerosis.
- Stage II — White sclerotic plaque on glans/foreskin.
- Stage III — Established phimosis, foreskin ring stenosis.
- Stage IV — External urethral meatal stenosis, dysuria.
- Stage V — Spongy urethral stricture, or ulceration/hyperkeratosis suspicious for malignancy.
Diagnosis and biopsy
Diagnosis is clinico-histological. The clinical picture is suggestive, but biopsy is MANDATORY in all patients to:
- Confirm the diagnosis.
- Exclude malignant transformation.
- Differentiate from other white lesions (vitiligo, psoriasis, leukoplakia).
- Guide therapeutic strategy.
Detailed clinical inspection
Plaque mapping, assessment of foreskin/glans/meatus, photographic documentation.
Diagnostic biopsy
From a representative area of sclerotic plaque, under local anaesthesia. Each suspicious area (ulceration, hyperkeratosis) — separate biopsy.
Histological examination
Epidermal atrophy, hyperkeratosis, dermal hyalinisation, lymphocytic infiltrate. Search for dysplasia or SCC.
Urethral evaluation
Uroflowmetry if dysuria or weak stream. For suspected spongy urethral stricture: ascending urethrogram or MRI.
Concomitant disease screen
Autoimmune screen (TSH, anti-TPO) in young patients or with autoimmune family history.
Risk of malignant transformation
Penile lichen sclerosus is internationally recognised as a premalignant condition:
- Lifetime risk of penile squamous cell carcinoma: 3–10%.
- Up to 30–50% of penile cancer patients have underlying BXO histologically.
- Non-HPV-dependent mechanism — distinct from condylomata.
- Risk is significantly reduced (but not zero) after circumcision.
- Diagnostic delay is associated with advanced-stage SCC.
Red flags — immediate biopsy
- New hyperkeratotic plaque (thick, hard).
- Non-healing ulcer > 4 weeks.
- Bleeding plaque.
- Tumour or palpable glans mass.
- Enlarged inguinal lymph nodes.
- Persistent pain or itching unresponsive to steroids.
See: penile cancer.
Treatment — medical and surgical
Treatment is individualised based on disease stage and extent. A stepwise approach is followed:
1. Topical ultra-potent corticosteroids — first line
Clobetasol 0.05% ointment, applied once daily for 8–12 weeks, then taper. Symptomatic remission achieved in 70–90% of early-stage cases. Monitor for skin atrophy (rare on penile skin).
2. Full circumcision — definitive treatment
Indication: BXO-related phimosis, steroid-refractory disease, recurrence. Curative in 76–100% of cases. Whole specimen sent for histology. See: adult circumcision.
3. Meatal stenosis — meatotomy or meatoplasty
For external urethral meatus stenosis from BXO. Often combined with circumcision.
4. Spongy urethral stricture — urethroplasty
For BXO strictures: buccal mucosa graft urethroplasty. Endoscopic incision (DVIU) has high recurrence and is NOT recommended.
5. Other therapies (selected cases)
Topical tacrolimus 0.1% (steroid-sparing), phototherapy, retinoids. Not first-line because of limited safety/efficacy data on the penis.
Post-treatment follow-up
Owing to the premalignant nature of the disease, long-term follow-up is mandatory for all patients, regardless of whether they had a circumcision or not:
- Reassessment 6 weeks after starting steroids — response evaluation.
- 6-monthly clinical review for the first 2 years.
- Annual clinical review for at least 5 years post-treatment (ideally lifelong).
- Photographic documentation for comparison.
- New biopsy of any suspicious lesion (new white plaque, ulceration, hyperkeratosis).
- Patient self-examination with clear instructions — report new findings.
- For urethral stricture: annual uroflowmetry.
In summary: With correct treatment and regular follow-up, the prognosis is excellent. Circumcision is the "gold standard" for persistent or refractory disease, but follow-up does not stop after surgery.
Prevention of complications and recurrence
- Early diagnosis — prompt biopsy of suspicious plaques.
- Strict adherence to topical steroid regimen.
- Good local hygiene — dry glans, avoid chronic moisture.
- Avoid irritants (detergents, fragrances).
- Full circumcision as definitive solution for refractory disease.
- Management of concomitant autoimmune conditions.
- Systematic lifelong follow-up for early detection of malignant transformation.
Frequently asked questions (FAQ)
What is penile lichen sclerosus?
Penile lichen sclerosus (LS) — formerly known as Balanitis Xerotica Obliterans (BXO) — is a chronic inflammatory skin disease affecting the foreskin and glans, leading to white sclerotic plaques, fibrosis, stenosis and — in 3–10% — malignant transformation to penile squamous cell carcinoma.
How common is it?
Prevalence is around 0.3–1% in adult men, peaking at ages 30–60. It is the most common cause of acquired phimosis in adults (up to 40% of adult phimosis is due to BXO).
Is it a premalignant condition?
Yes. Penile lichen sclerosus is a recognised predisposing condition for squamous cell carcinoma of the penis (3–10% lifetime risk). Early diagnosis, treatment and regular follow-up are critical.
What are the main symptoms?
White sclerotic plaques on the glans and foreskin, thickening and loss of elasticity, foreskin ring stenosis (phimosis), fissures, itching, pain on erection, urethral meatal stenosis with dysuria.
How is the diagnosis made?
Diagnosis is clinical, but biopsy is ALWAYS required for confirmation and to exclude malignancy. Histology shows epidermal atrophy, hyperkeratosis, dermal hyalinisation and lymphocytic infiltrate.
What is the treatment?
First line: topical ultra-potent corticosteroids (clobetasol 0.05%) for 8–12 weeks. For phimosis or recurrent disease: full circumcision (curative in 76–100% of cases). For urethral stricture: urethroplasty with buccal mucosa graft.
Is circumcision curative?
In the majority of cases yes. Full circumcision with histological examination of the entire specimen is curative in 76–100% of patients. However, regular glans surveillance is required for at least 5 years.
How frequent should follow-up be?
Every 6 months for the first 2 years, then annually for at least 5 years. Any new white plaque, ulceration or hyperkeratosis warrants immediate reassessment and biopsy.
Related topics
Book an appointment in Rhodes
If you notice white plaques, sclerosis or progressive phimosis, early diagnosis with biopsy and appropriate treatment protect against complications and malignant transformation.
Scientific literature
- EAU Guidelines on Penile Cancer (2024) — Premalignant lesions and penile lichen sclerosus — uroweb.org
- Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol 2015;29(10):e1-e43 — pubmed.ncbi.nlm.nih.gov
- Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 2018;178(4):839-853 — pubmed.ncbi.nlm.nih.gov
- Edmonds EV, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012;26(6):730-7 — pubmed.ncbi.nlm.nih.gov
- Kulkarni S, Barbagli G, Kirpekar D, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55(4):945-54 — pubmed.ncbi.nlm.nih.gov
Meet the doctor
Dr. Marinos Vasilas, Urologist – Andrologist
Dr. Marinos Vasilas offers comprehensive management of penile lichen sclerosus: histological diagnosis, individualised medical therapy, full circumcision and urethroplasty when needed, with long-term oncological surveillance.
See full profile
